“Research into the therapeutic potential of illegal “psychedelic” drugs to treat an assortment of mental health conditions is undergoing a modern-day renaissance. A host of published studies in the field is showing promise for psychedelics, such as psilocybin — the active ingredient in “magic mushrooms” — LSD and MDMA (ecstasy) to help treat alcoholism, depression, drug addiction and severe anxiety caused by serious or terminal illness. With stage three trials now on the horizon, these new treatment modalities are gaining main stream recognition and acceptance.”
